-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The top 10 drugs sold have changed their blood
01
01Announcement of Top 10 Drug Sales
Announcement of Top 10 Drug SalesAugust 9, Henan Province Pharmaceutical Procurement Service Center issued "on the first half of 2021 the province's drugs online transactions publicity"
Official data show that in the first half of the year, there were 3498 medical institutions (provincial medical institutions and some retail pharmacies), 2,357 manufacturing companies, and 436 operating companies that traded 15,823 drugs through the platform, with a transaction amount of 28.
According to the Henan Province’s previous announcement of the province’s drug online transactions in the first half of 2020, there were 3,500 medical institutions (provincial medical institutions and some retail pharmacies), 2,343 manufacturing companies, and 449 operating companies that traded through the platform in the first half of the year.
In contrast, the number of pharmaceutical institutions, manufacturing companies, and pharmaceutical transactions that participated in the transaction this year has all decreased, but the transaction volume has increased
According to the amount of online transactions, the top 10 drugs sold in Henan Province in 2021 are as follows:
02
024 drugs fell out of the top 10 sales
4 drugs fell out of the top 10 salesComparing the top 10 drugs with online transaction value in Henan Province in the first half of 2020 and 2021, it can be seen that a total of 4 drugs fell out of the top 10 sales, namely CP Tianqing’s Anlotinib, AstraZeneca’s Budesonide Suspension, and Shaanxi Step.
Qilu's bevacizumab injection, Suzhou Shengdia Biopharmaceutical's Carrelizumab powder injection, Yangzijiang Pharmaceutical's dexmedetomidine injection, and Yuekang Pharmaceutical's Ginkgo biloba extract Injection will enter the top 10 online transactions in Henan Province in the first half of 2021
Roche's trastuzumab powder injection is the drug that has ranked first in the amount of online transactions in Henan Province this year
This variety is one of Roche's "troikas" and has long occupied the list of TOP10 drug sales.
It is reported that Pfizer’s atorvastatin calcium, which is at the top of the list this time, was out of the first 4+7 volume purchase at the end of 2018, and the 4+7 expansion volume purchase in September 2019 did not win the bid.
It is worth noting that in the fifth batch of procurement results, Jiangsu's iodixanol large infusion has been unsuccessful.
03
03A batch of pharmaceutical companies ranks up
A batch of pharmaceutical companies ranks upIn addition to publicizing drug sales, the "Notice" also announced the online supply and distribution of drug manufacturers
In the first half of the first half of the year, the top 10 manufacturers of the top 100 online suppliers were: Jiangsu Hengrui Pharmaceutical Co.
With reference to Henan Province's 2020 annual rankings, Cyberlan's query found that among domestic pharmaceutical companies, Hengrui is still in the leading position.
It can be seen from the top 10 manufacturers that the supply amount is more than 100 million yuan
However, the rankings of a number of pharmaceutical companies have improved rapidly.
Shanghai Shangyao No.
Hengrui's subsidiary Suzhou Shengdia Bio-Pharmaceutical Co.
, Ltd.
rose from 48 last year to 30 this year.
From the perspective of supply, it was 188 million last year and reached 133 million in the first half of this year
.
In the first half of the first half of the online distribution amount of the top 50 operating companies are: China Resources Henan Pharmaceutical Co.
, Ltd.
; Sinopharm Holdings Henan Co.
, Ltd.
; Henan Kangxin Pharmaceutical Co.
, Ltd.
; Chongqing Pharmaceutical Group Henan Co.
, Ltd.
; Henan Pharmaceutical Co.
, Ltd.
; Sinopharm Holding Luoyang Co.
, Ltd.
; Sinopharm Holding Zhumadian Co.
, Ltd.
; Henan Jiuzhoutong Pharmaceutical Co.
, Ltd.
; Sinopharm Holding Anyang Co.
, Ltd.
; Sinopharm Holding Xinxiang Co.
, Ltd
.
.
The top 10 medical institutions with purchase amount in the first half of the year were: First Affiliated Hospital of Zhengzhou University, Henan Provincial People's Hospital, Henan Tumor Hospital, Zhengdong District of First Affiliated Hospital of Zhengzhou University, Zhengzhou Central Hospital, Nanyang Central Hospital, Henan The First Affiliated Hospital of the University of Traditional Chinese Medicine, the First Affiliated Hospital of Xinxiang Medical College, Xinyang Central Hospital, and the First People's Hospital of Shangqiu City
.
The total amount of the top three medical institutions is more than 1 billion yuan.
They are: the First Affiliated Hospital of Zhengzhou University 2.
275 billion yuan, Henan Provincial People's Hospital 1.
461 billion yuan, and Henan Tumor Hospital 1.
118 billion yuan
.
With the accelerating progress of the consistency evaluation of generic drugs and the advancement of national centralized procurement, the replacement of original research drugs by generic drugs is gradually accelerating.
What changes will occur in the future pharmaceutical market structure is still worthy of attention
.
Although the data released this time is only for one province, Henan, as a major pharmaceutical province, may have a certain representative effect on the changes in the market structure of other drugs
.
Attachment: the top 100 manufacturers in Henan Province in the first half of the year
